Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (5): 313-314.
Previous Articles Next Articles
CAO Jianying1, QU Xiujun1, QIN Ying2, SHI Zhongge1, ZHANG Anchao1, LI Zhongliang3,*
Received:2019-03-16
Revised:2019-06-11
Online:2019-05-20
Published:2019-06-11
CLC Number:
CAO Jianying, QU Xiujun, QIN Ying, SHI Zhongge, ZHANG Anchao, LI Zhongliang. Two Cases of Neonatal Hypocalcemia Induced by Sodium Phosphate for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(5): 313-314.
Add to citation manager EndNote|Ris|BibTeX
| [1] 林万龙,陈瑶,杨剑辉.儿童辅助治疗药物磷酸肌酸钠专项点评前后合理性比较[J].中国医院药学杂志,2017.37(5):478-481. [2] 《中国国家处方集》编委会.《中国国家处方集》(化学药品与生物制品卷·儿童版)[M].人民军医出版社,2013:213. [3] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M]. 4版.人民卫生出版社..2018:562-563. [4] 李凤敏,戴军,陈玉霞,等.兰州市小于18岁健康儿童心肌酶谱参考值趋势性分析[J].实用儿科临床杂志,2011,26(13):1022-1024. [5] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M]. 4版.人民卫生出版社,2018:763-764. [6] 焦颖,马建荣,刘巍巍.磷酸肌酸钠静脉用药引起新生儿低钙血症的临床分析[J].中国临床药学杂志,2016,25(6):370-373. [7] 章樱,陈国庆,张勤.磷酸肌酸钠对新生儿缺氧缺血性脑病氧化应激的影响及心肌损伤的保护作用[J].中华全科医学,2016.14(5):786-789. [8] 张彤,磷酸肌酸钠对新生儿心肌损伤的疗效观察[J].医学综述,2012,18(22):3872-3874. [9] 缪珀,孙斌,冯星.磷酸肌酸钠治疗新生儿窒息后心肌损伤的meta分析[J].中国当代儿科杂志,2012,14(3):172-176. [10] Kraft M D.Phosphorus and calcium: a review for the adult nutrition support clinician[J].Nutr Clin Pract,2015,30(1):21-33. [11] Konan D J,Amon-Tanoh-Dick F, Aka J,et al. Determinants of neonatal serem calcium in a peripheral maternity in Abidjian[J].Pan Afr Med,2015,21(20):390. [12] 吉林英联生物制药股份有限公司.杜玛注射用磷酸肌酸钠[EB/OL].(2013-02-04) [2019-04-17].http://www.jlylsw.com/ebook/e1/ . [13] Levy-Shraga Y,Dallalzadeh K,Stem K,et al.The many etiologies of neonatal hypocalcemic seizures[J].Pediatr Emerg Care,2015,31(3):197. [14] 王丹. 药物不良反应主动监测及其发展趋势[J].中国药物警戒. 2015,12(10):600-602. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
